SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-20-004632
Filing Date
2020-04-29
Accepted
2020-04-29 16:16:54
Documents
11
Period of Report
2020-06-16
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A ndra_pre14a.htm DEF 14A 538570
2 IMAGE endralifesciencesincproxy000.jpg GRAPHIC 4645
3 IMAGE endralifesciencesincproxy001.jpg GRAPHIC 1168
4 IMAGE endralifesciencesincproxy002.jpg GRAPHIC 1065
5 IMAGE endralifesciencesincproxy003.jpg GRAPHIC 991
6 IMAGE endralifesciencesincproxy004.jpg GRAPHIC 1228
7 IMAGE ndra_pre14a000.jpg GRAPHIC 6824
8 IMAGE ndra_pre14a001.jpg GRAPHIC 4568
9 IMAGE ndra_pre14a002.jpg GRAPHIC 9878
10 IMAGE ndra_pre14a003.jpg GRAPHIC 2627
11 IMAGE ndra_pre14a004.jpg GRAPHIC 9878
  Complete submission text file 0001654954-20-004632.txt   600374
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37969 | Film No.: 20830552
SIC: 3845 Electromedical & Electrotherapeutic Apparatus